I believe the Chinese need country of origin approval - TGA - so application can be made there. FDA is frustrating; they haven't begun trials for adults yet. Anyhow, no negative thoughts today!
Ann: ResAppDx-EU for Adult Respiratory Disease Receives CE Mark, page-25
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #